Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2018 Dec 1.
Published in final edited form as: Mol Biochem Parasitol. 2017 Oct 6;218:16–22. doi: 10.1016/j.molbiopara.2017.10.001

Comparison of two methods for transformation of Plasmodium knowlesi: direct schizont electroporation and spontaneous plasmid uptake from plasmid-loaded red blood cells

Roberto R Moraes Barros a, Tyler J Gibson a, Whitney A Kite a, Juliana M Sá a, Thomas E Wellems a,§
PMCID: PMC5682199  NIHMSID: NIHMS912856  PMID: 28988930

Abstract

Human infections from Plasmodium knowlesi species present challenges to malaria control in Southeast Asia. P. knowlesi also offers a model for other human malaria species including Plasmodium vivax. P. knowlesi parasites can be cultivated in the laboratory, and their transformation is standardly performed by direct electroporation of schizont-infected red blood cells (RBCs) with plasmid DNA. Here we show that the efficiency of direct electroporation is exquisitely dependent on developmental age of the schizonts. Additionally, we show that transformation of P. knowlesi can be achieved without direct electroporation by using the parasite’s ability to invade and take up DNA from plasmid-loaded RBCs. Transformation with plasmid-loaded RBCs does not require labor-intensive preparations of schizont-infected RBCs as for direct electroporation, and parasite damage from high voltage discharge is avoided. Further studies of the mechanism of spontaneous DNA uptake may suggest strategies for improved transformation and provide insights into the transport pathways of apicomplexans.

Keywords: malaria, transfection, cell electroporation, luciferase, genetic modification

1. Background

Plasmodium knowlesi, a natural parasite of macaque monkeys, is now a major cause of malaria in Malaysia, where 10% of the clinical cases it causes are considered severe and 1–2% result in death [13]. Another 8 countries in Southeast Asia report P. knowlesi infections [1], a fact that expands the agenda of malaria control efforts largely focused on the elimination of P. falciparum and P. vivax [4].

In addition to its importance as an emerging pathogen, P. knowlesi provides an important model for drug and vaccine research, and it provides a system for studies of other malaria parasite species that are less tractable for experimental investigation [5, 6]. An example is the P. vivax species, a leading cause of human malaria in the same evolutionary clade as P. knowlesi [7, 8]. While methods for effective in vitro cultivation of P. vivax remain unavailable, P. knowlesi cultures in human as well as rhesus macaque red blood cells (RBCs) are useful for a range of experimental studies [911]. The full P. knowlesi life cycle can be supported through rhesus macaques and Anopheles mosquitoes in the laboratory, and genetic transformation of P. knowlesi parasites can be achieved in vivo and in vitro [9, 1214].

P. knowlesi transformation methods have relied on the direct electroporation of infected RBCs [9, 15]. Likewise, transformation of P. falciparum-infected RBCs was performed only by direct electroporation until the development of an alternative method that took advantage of spontaneous DNA uptake by parasites in plasmid-loaded RBCs [16]. Comparative studies showed that the spontaneous uptake method is both convenient and efficient [17], and it has served for manipulations and knock-outs of genes that affect important phenotypes, including antigenic variation, drug resistance and parasite invasion of RBCs [1821]. We now report successful transformation of P. knowlesi by DNA uptake from plasmid-loaded rhesus RBCs, and we compare the results to the outcomes of transformation by electroporation of schizont-infected RBCs.

2. Methods

2.1 Plasmid constructs

Plasmid pHDEF1i-luc (Fig. 1A) contains the firefly luciferase cassette (fLuc) under control of a 1.4 kb 5′ untranslated region (UTR) from the Plasmodium berghei elongation factor 1–α gene (pbef1-α) and a 0.6 kb 3′UTR from the P. falciparum histidine rich protein 2 gene (pfhrp-2). In previous work, the pbef1-α 5′ UTR was used to promote expression of fLuc in P. knowlesi [13]; it also served as a bidirectional promoter to drive the simultaneous expression of the human dihydrofolate reductase gene (hdhfr) and a fLuc cassette in opposite directions [19].

Fig. 1.

Fig. 1

Plasmid maps and the timelines of two transformation methods. A The pHDEF1i-luc plasmid contains a firefly luciferase fLuc cassette driven by P. berghei ef1-α 5′ UTR (pbef1-α 5′). The pD-PfCam-luc plasmid expresses fLuc and contains the hdhfr gene that confers resistance to WR99210. The fLuc cassette is driven by the P. falciparum cam 5′ UTR (pfcam 5′) and the hdhfr cassette is driven by the P. chabaudi dts 5′ UTR (pcdts 5′). The arrows indicate directions of transcription; pfhrp2 3′ and pfhsp86 3′ indicate 3′ UTR terminating sequences from the pfhrp2 and pfhsp86 genes. B For transformation by the schizont electroporation method, schizont-infected RBCs were isolated by Percoll gradient, electroporated in the presence of plasmid, and placed into culture for luminescence measurement 48 h later. For transformation by spontaneous DNA uptake, plasmid-loaded RBCs were added to asynchronous pRBCs. Freshly-prepared, plasmid-loaded RBCs were added again at 24 h, and the cells were harvested from the culture at 72 h for luminescence measurement.

Plasmid pD-PfCam-luc (Fig. 1A) was generated by replacing the pfcrt gene in plasmid pDC/CRT-FLAG [22] with the fLuc cassette, between the XhoI restriction enzyme sites. It thus carries the fLuc cassette under control of a 0.6 kb 5′ UTR sequence from the P. falciparum calmodulin gene (pfcam) and a 0.8 kb 3′ UTR sequence form P. falciparum heat shock protein 86 (pfhsp86). pD-PfCam-luc also contains the hdhfr cassette under control of a 0.6 kb 5′ UTR from the P. chabaudi dhfr-ts gene (pcdts 5′), and a 0.8 kb 3’UTR from pfhrp2.

2.2 Rhesus red blood cells and P. knowlesi cultures

Rhesus blood was obtained according to the NIH Guidelines for Animal Care and Use, under an Animal Study Proposal approved by the NIAID Animal Care and Use Committee (ACUC). Samples were collected into vacutainer tubes coated with sodium heparin (BD, Franklin Lakes, NJ, USA) and centrifuged at 800 × g for 3 min; plasma was removed and the RBCs were washed once with incomplete RPMI (iRPMI, consisting of 0.26% sodium bicarbonate in RPMI-1640 (with 25 Mm Hepes and 50 μg/ml hypoxanthine, KD Medical, Columbia, MD, USA)). After the wash, the RBCs were suspended to a final 50% hematocrit (hct) in complete RPMI (cRPMI, consisting of iRPMI supplemented with 10 mg/L gentamicin, and 1% Albumax II (Life Technologies, Carlsbad, CA, USA). This RBC suspension was stored as stock at 4°C and used within 2 weeks of processing.

P. knowlesi H strain cultures were initiated from thawed cryopreserved stocks gifted by Dr. Sanjay Desai (LMVR, NIAID). The cultures were maintained in cRPMI with rhesus RBCs at 5% hct, under a 90% N2/5% CO2/5% O2 gas mixture at 37 °C with daily media changes. Parasite development and propagation through the P. knowlesi 24-hour asexual blood stage cycle was monitored by microscopy of thin blood films fixed in methanol and stained for 15 min with 20% Giemsa (Sigma-Aldrich, St. Louis, MO, USA). Parasitemias were estimated by counting the number of parasitized RBCs (pRBCs) per 1,000 RBCs. Cultures were maintained with parasitemias between 0.5 and 10.0%. Parasitemias increased ~3–5-fold/day in Albumax supplemented RPMI (cRPMI), similar to previous reports of P. knowlesi growth in serum supplemented RPMI [9, 10].

2.3 Percoll gradient for schizont enrichment

Synchronized P. knowlesi cultures and schizonts were obtained by a Percoll step-gradient modified from that described for P. falciparum [23, 24]. Briefly, cultures containing > 3% segmented schizonts were centrifuged at 800 × g for 3 min, and a 300 μL pellet containing the pRBCs was resuspended in 3 mL of cRPMI. This mixture was gently placed onto a 35%/65% Percoll (GE Healthcare Life Sciences, Pittsburgh, PA, USA) step-gradient and centrifuged (1500 × g, 15 min, no brake). Late-stage schizonts were collected in a 500 μL volume at the gradient step and centrifuged at 800 × g for 3 min. The recovered schizonts (20 μL volume) were washed once with 5 mL of cRPMI.

2.4 Transformation of P. knowlesi by electroporation of schizont-infected RBCs

Direct electroporation of P. knowlesi schizont-infected RBCs was performed as described by Janse et al. [15] and Moon et al. [9]. For each electroporation experiment, a total of 1 × 107 or 3.5 × 107 schizont-infected RBCs was purified by Percoll gradient from a 20 mL synchronized P. knowlesi culture (5% hct). The recovered cells (up to 50 μL) were suspended in 100 μL of P3 primary cell solution (Lonza, Basel, Switzerland) and mixed with 20 μg of plasmid DNA in 10 μL of TE buffer (10 mM Tris-HCl, 1 mM EDTA, pH 8.0). This suspension was transferred to a 4D Nucleofector XL cuvette and subjected to electroporation in the Lonza 4D Nucleofector System (Lonza), using program FP158. Immediately after electroporation, the suspension was placed into a 2 mL tube containing 500 μL of cRPMI and 300 μL of stock 50% hct rhesus RBCs. After 30 min at 37°C in a shaking incubator (250 rpm), the mixture (900 μL total) was transferred to a 25 cm2 vented culture flask (Thermo Fisher, Waltham, MA, USA) with 5 mL of fresh cRPMI under a 90% N2/5% CO2/5% O2 gas mixture. For drug selection experiments, an additional 200 μL of fresh 50% hct rhesus RBCs was added to cultures. Cells were collected 48 h later for luciferase assays or maintained in culture for selection under 1 nM WR99210 pressure (Fig. 1B).

2.5 Transformation of P. knowlesi by DNA uptake from plasmid-loaded rhesus RBCs

For plasmid loading, 300 μL of pelleted rhesus RBCs were washed twice by centrifugation and resuspension in 5 mL cytomix (120 mM KCl, 0.15 mM CaCl, 2 mM EGTA, 5 mM MgCl2, 10 mM K2HPO4/KH2PO4, 25 mM Hepes, pH adjusted to 7.6 with KOH) [25]. The RBCs were recovered, placed in a 1.5 mL microcentrifuge tube with 100 μL cytomix containing 40 μg of plasmid DNA, and transferred to a 0.2 cm electroporation cuvette (Bio-Rad, Hercules, CA, USA). Electroporations of the uninfected RBCs were performed in a Bio-Rad Gene Pulser II at 310V and 975 μF, with resulting time constants of 20–35 ms. The plasmid-loaded RBCs were washed twice with 5 mL of iRPMI and used immediately.

For transformation of parasites by spontaneous DNA uptake, the plasmid-loaded RBCs were added to 10 mL of cRPMI in a 25 cm2 flask, for an hct of 2.5%. A concentrated suspension (50 μL) of 3% asynchronous pRBCs was added to introduce a parasitemia of 0.5% (1.5 × 107 pRBCs total) and an hct of 3%. The flask was maintained under culture conditions and, after 24 h, fresh plasmid-loaded RBCs were again added, for a final culture hct of 5% with an estimated 90% of RBCs from plasmid-loaded stock. After another 48 h in culture, cells were collected for luciferase assays (Fig. 1) and/or continued in culture under 1 nM WR99210 pressure.

2.6 Luciferase Assays

To remove hemoglobin and avoid a possible quenching effect of luciferase assay signal, pRBCs were treated with saponin: up to 500 μL of pRBCs were collected from cultures by centrifugation (800 × g, 3 min), overlying supernatant was removed, and the cells were twice suspended and re-pelleted in 0.15% saponin in 1× PBS (10 mM PO 43−, 137 mM NaCl, 2.7 mM KCl, pH 7.4). After washing twice with 1× PBS, the parasites were pelleted, resuspended in 50 μL 1× Cell Culture Lysis Reagent (Luciferase Assay System (Promega, Madison, WI)) and incubated for 10 min at room temperature. The resulting lysate (volume 50 – 60 μL) was cleared by centrifugation (1 min at 10600 × g) and 20 μL of the supernatant (upper liquid layer) was mixed with 100 μL of Promega Luciferase Assay Reagent for luminescence assessment with a GloMax 20/20 Luminometer (10 s integration time). Measurements were collected in technical duplicates and averaged for analysis.

2.7 WR99210 selection of P. knowlesi transformants

Parasites transformed by the pD-PfCam-luc plasmid were selected by addition of 1 nM WR99210 to the daily culture media changes (selection attempts failed at the higher levels of 2.5 nM used in another study [9]). Samples from the culture (80 μL packed RBCs volume) were collected for luciferase assays at the time selection was initiated and every 4 days afterwards. To maintain a steady hct, fresh rhesus RBCs were added to replace the cells removed by sampling.

3. Results

3.1 Parasite survival and luciferase activity after transformation by two different methods

To assess parasite survival and growth following transformation by the two methods, we compared total parasite numbers in the cultures before and after transformation with plasmid pHDEF1i-luc. In direct electroporation experiments (SET#1, SET#2, SET#3) a 3-fold decrease was observed, from 3.5 × 107 schizont-infected RBCs electroporated to an average of 1.15 ×107 morphologically intact parasites 48 h later, indicating high mortality after electroporation (Fig. 2A, Table S1). This evidence for extensive parasite damage was accompanied by a high prevalence of parasite debris and pyknotic forms. In contrast, in transformation experiments with plasmid-loaded RBCs (PUT#1, PUT#2, PUT#3), the parasite number increased 22-fold over 72 h, from 1.5 × 107 in the initial inoculum to 33 × 107 parasites. Pyknotic forms and parasite debris were absent from the transformations with plasmid-loaded RBCs.

Fig. 2. Counts and luciferase activities of parasites transformed by schizont electroporation or spontaneous plasmid uptake.

Fig. 2

A Number of morphologically-intact parasites in cultures of P. knowlesi obtained after direct electroporation of 3.5 × 107 schizont-infected RBCs (left, harvested for luminescence measurement at 48 h) or by spontaneous DNA uptake after the inoculation of 1.5 × 107 asynchronous parasites into plasmid-loaded RBCs (right, harvested at 72 h). The graphs show averages ± standard errors of the mean (SEMs) from three independent experiments. B Luciferase activities of P. knowlesi parasites transformed with pHDEF1i-luc by either direct electroporation of schizont-infected RBCs (left panel), or by spontaneous DNA uptake in plasmid-loaded RBCs (right panel). The graphs show averages ± SEMs from three independent experiments in which luciferase measurements were obtained 48 h after transformation by schizont electroporation or after 72 h of culture for spontaneous DNA uptake from plasmid-loaded RBCs. Mock: control transformation experiments performed in parallel without plasmid; no parasites: control experiments with plasmid and uninfected RBCs only; LUs: luminescence units.

In three independent experiments, we observed that the average luminescence signal from electroporation of synchronized schizonts was overall greater than from mixed parasite stages transformed by plasmid-loaded RBCs (Fig. 2B). Specifically, 48 h signals (average ± standard deviation − SD) of 34,659 ± 883, 16,612 ± 1,254, and 22,790 ± 161 LUs were obtained in three experiments with PHDEF1i-luc-electroporated schizonts (Table S2). In comparison, signals of 2,315 ± 317, 4,414 ± 16, and 1,342 ± 8 LUs were obtained from parasites grown for 72 h in PHDEF1i-luc-loaded rhesus RBCs (Table S3).

3.2 Electroporation efficiency varies greatly between developing, nearly mature, and mature schizonts

Morphological differences distinguish developing (early-stage), nearly mature (mid-stage) and mature (late-stage) schizonts of P. knowlesi as they progress to merozoite release [26] (Fig. 3). Late-stage segmented schizonts of Plasmodium berghei rodent parasites have been stated to be best for transfection and genetic modification [15]. We therefore designed experiments to test the effect of schizont maturity on transformation efficiency of P. knowlesi parasites.

Fig. 3. Images of representative stages from tightly synchronized P. knowlesi cultures.

Fig. 3

Parasitized RBCs observed by light microscopy (Giemsa stain). Developing schizonts are observed as soon as 18 h after RBC invasion by synchronized merozoites. Nearly mature and mature schizonts are detected 21 h after invasion and can be observed until burst and merozoite release 24 h after RBC invasion. Scale bar: 5 μm

P. knowlesi parasites were tightly synchronized by two consecutive Percoll density gradients, allowed to mature through their erythrocytic cycle in the presence of fresh RBCs, and subsequently harvested for schizont samples 18 h, 21 h and 24 h after merozoite invasion (Table 1). After direct electroporation of these developing, nearly mature, and mature schizonts with pD-PfCam-luc, the parasites were returned to separate flasks, maintained under culture conditions, and taken for luminescence measurements precisely 48 h (2 cycles) after reinvasion. Results showed dramatic differences in the signals from the 18 h, 21 h and 24 h schizont preparations (Table 1). In experiment SS#1, luminescence signals (average ± SD) jumped from 3,620 ± 126 LUs in the 18 h preparation to 1,465,131 ± 581,935 LUs in the 21 h preparation, before decreasing to 526,487 ± 21,436 LUs in the 24 h preparation. In experiment SS#2, luminescence jumped from levels of 1,322 ± 4 and 161,190 ± 4,941 LUs in the 18 h and 21 h preparations to 4,055,306 ± 221,242 LUs in the 24 h preparation. The difference of peak signal times in experiments SS#1 and SS#2 likely resulted from a few hours difference in the maturity of the schizont preparations. Evidence for this difference is found in the stage distribution of the SS#1 preparation at 24 h, which showed that nearly half of the parasites were young ring forms from merozoite release and reinvasion (Table 1). Young rings forms do not transform efficiently by direct electroporation, likely explaining the decrease of luminescence at 24 h relative to the 21 h preparation.

Table 1.

Stage distributions and parasite numbers at the electroporation timepoints

Experiment ID* Rings Trophozoites Developing schizonts Nearly mature and mature schizonts Gametocytes Parasitemia Luciferase signal (LUs)
SS#1 18 h 1 6 4 1 0 1.20% 3,620 ± 126
SS#1 21 h 0 1 5 5 0 1.10% 1,465,131 ±581,935
SS#1 24 h 7 2 3 3 0 1.50% 526,487 ±21,436
SS#2 18 h 0 18 9 0 0 2.70% 1,322 ± 4
SS#2 21 h 1 8 15 7 0 3.10% 161,190 ± 4,941
SS#2 24 h 0 3 13 16 0 3.20% 4,055,306 ± 221,242
*

Schizonts were harvested for electroporation 18 h, 21 h and 24 h after reinvasion. Counts represent numbers of the different stages per 1,000 RBCs. Between 1 × 107 and 3 × 107 schizonts in a 100 μL volume of pRBCs were used for each electroporation.

Luciferase measurements are from P. knowlesi schizonts harvested two days after direct electroporation (means ± standard deviations from two technical replicates; Table S4). LUs: Luminescence units.

3.3 Parasite growth and transformant selection using WR99210

To study the recovery of resistant parasites obtained with each transformation method followed by drug selection, we modified P. knowlesi parasites with plasmid pD-PfCam-luc, which confers both luciferase expression and WR99210 resistance (Fig. 1A). Transformants were subjected to selection with 1nM WR99210, either 48 h after schizont electroporation or 72 h after the first addition of plasmid-loaded RBCs to parasite culture. Almost all parasites were quickly eliminated from culture so that survivors were rare or undetectable in thin smears four days after application of drug pressure (Fig. 4A, Table S5); however, WR99210-resistant parasites subsequently grew out with each method. In three independent experiments with directly-electroporated schizont-infected RBCs (SE#1, SE#2 and SE#3), parasitemias > 0.01% were detected 8 days after transfection of the 24 h stages, 8 – 12 days after transfection of 21 h stages, and 14 – 18 days after transfection of 18 h stages excepting one culture that remained negative (SE#1 18 h) (Table S5). In two independent transformations by DNA uptake from plasmid-loaded RBC (PU#1, PU#2), parasitemias ≥ 0.01% were observed on days 15 and 17 (Table S5). After WR99210 selection, all drug-resistant parasites showed a growth rate of 3 – 5-fold/day, similar to that of un-transfected parasites.

Fig. 4. Parasitemia and luciferase measurements of P. knowlesi pD-PfCam-luc transformants under WR99210 selection.

Fig. 4

A Parasitemias of morphologically-intact transformants obtained by direct electroporation of schizont-infected RBCs with pD-PfCam-luc or by growth in pD-PfCam-luc-loaded RBCs. Selection of the drug-resistant parasites by 1 nM WR99210 was initiated 48 h after schizont electroporation or 72 h after the first addition of plasmid-loaded RBCs for spontaneous transformation (grey arrows). B Luminescence measurements from samples of the transformant cultures. For each measurement, an 80 μL volume containing ~8 × 107 RBCs was removed from the culture and used for luciferase assay. Individual data points represent averages ± standard errors of the mean from three independent experiments of schizont electroporation and from two independent experiments of spontaneous plasmid uptake.

Along with parasitemia counts, luciferase signals of the WR99210-selected transformants were assessed over the course of drug selection (Fig. 4B, Table S6). Luminescence levels obtained 48 h after direct electroporation varied according to the age of schizonts electroporated. Transformants from developing schizonts (18 h stages) in three independent experiments (SE#1, SE#2 and SE#3), presented 48 h luciferase signals (average ± SD) of 257 ± 12, 1,177 ± 38, and 1,214 ± 6 LUs. Transformants from 21 h schizonts presented signals of 41,033 ± 5,552, 3,715 ± 134, and 22,395 ± 151 LUs, whereas the transformants from 24 h schizonts yielded the highest signals, 156,958 ± 7,870, 229,884 ± 5,173, and 117,033 ± 483 LUs. Fig. 4B shows plots of the average signals ± standard error of the mean (SEM) of the experiments. Following the initial period of WR99210 selection, these signals rose in general accord with the expansion of transformant populations in the cultures; only one experiment (SE#1 18 h) showed no development of luciferase activity (Table S6), consistent with the absence of any microscopically observed transformants as noted above.

In two independent experiments (PU#1, PU#2), transformants obtained by the plasmid uptake method presented 72 h luciferase signals (average ± SD) of 1,269 ± 18 and 1,588 ± 31 (Table S6). Signals then decreased 1.6 – 2.5-fold by day 7, after which they rose at a rate similar to that of the transformants from electroporated schizonts (Fig. 4B).

4. Discussion

In comparative studies of P. knowlesi transformation methods, our results have led to two findings: (1) transformation efficiency by direct electroporation is highest with late-stage mature schizonts; and (2) stably-transformed P. knowlesi parasites can be efficiently obtained by taking advantage of their ability to spontaneously take up DNA from host RBC. DNA uptake from plasmid-loaded RBCs was originally described for P. falciparum parasites and has been widely used for the genetic manipulation of these parasites[16, 18, 19, 21, 27]. The success of this method now with P. knowlesi suggests that spontaneous DNA uptake from host RBCs is a general property that may support transformation of additional Plasmodium species and perhaps some other members of the broad alveolate group.

Direct-electroporation of late (23 – 24 h) P. knowlesi schizont stages with luc plasmids yielded populations with much greater luciferase activity than did direct-electroporation of younger developing (18 h) schizont stages. Use of mature, well-segmented schizonts thus provided the highest transformation efficiencies, as has been observed also for P. berghei [15]. Electroporation of early 18 h stages with pD-PfCam-luc produced signals 100–600-fold lower than similar electroporation of the well-segmented 24 stages; indeed, transformants from the 18 h stages in one case showed no detectable luminescence or survival after WR99210 selection. In transformation experiments involving spontaneous plasmid uptake, results from mixed-stage parasites exposed to pD-PfCam-luc-loaded RBCs were comparable to the successful electroporations of 18h stages, as assessed by yield of transformants and their luciferase signals.

With both transformation methods, intact parasites in thin blood smears decreased to microscopically unobservable levels 4 – 8 days after initiation of WR99210 selection pressure. The period for outgrowth of drug-resistant parasites with both protocols was therefore longer than reported by Moon et al. [9], who observed expanding populations of transformants after 4 days of pressure. Heterologous promoters in our constructs may account for some of this difference, as the selection times of 4 days were observed with markers under the control of endogenous 5′UTRs. Weaker activity of heterologous promoters may require higher plasmid copy number to allow selection of drug resistant parasites, similar to the copy number increase observed in P. falciparum transformants subjected to higher drug concentrations [28]. Furthermore, the selection period observed in the spontaneous plasmid uptake method (15 – 17 days, 107 pRBC) was similar to reports of direct electroporation of asynchronous cultures using heterologous constructs (two weeks, 109 pRBC) [12, 13]. We also note that the interval to select transgenic parasites by the spontaneous plasmid uptake method was about one-half to two-thirds of the time commonly observed for P. falciparum [17], in agreement with different blood stage cycle periods of these two species (24 h for P. knowlesi; 48 h to P. falciparum) [26].

Spontaneous uptake of DNA from plasmid-loaded RBCs offers several advantages of convenience over the schizont electroporation method for transformation of P. knowlesi. Stored RBCs can be quickly electroporated with plasmid and simply placed into an ongoing P. knowlesi culture for immediate initiation of transformation. An inoculum of 1.5 ×107 asynchronous parasites (50 μL of packed pRBCs at 3% parasitemia) is sufficient, avoiding the resource requirements to synchronize parasites by density gradients and prepare large numbers of purified schizonts for electroporation. Transformation by plasmid-loaded RBCs also avoids adverse effects of Percoll density gradients [29] and stresses from electroporation that may affect transient signals used for studies of regulatory sequences.

Despite broad use of spontaneous uptake for Plasmodium transformation, the mechanism of plasmid uptake by parasites remains obscure. In single-particle trafficking experiments with fluorescently labeled DNA in CHO cells, electroporation was found to promote DNA/membrane interactions at the cell surface and subsequent entry of plasmid aggregates, possibly in vesicles by endocytosis or directly through electropores [30]. The plasmids were actively transported by fast microtubule-related and slow actin filament-related processes along the cytoplasmic network to the nuclear envelope, where they then crossed into the nucleus and were expressed. Analogous trafficking and expression processes seem likely in Plasmodium-infected RBCs; however, DNA/membrane interactions and plasmid incorporation happen spontaneously in these cells without any need for electroporation. Plasmid DNA may be taken up with host RBC contents into parasite cytostomes and phagotrophs, which have been found to convey hemoglobin either directly or via intermediate vesicles to a central digestive vacuole [31] [32]. For expression to happen, DNA in these hemoglobin-containing compartments would have to escape for redirection and entry into the nucleus. Apart from cytostomes and phagotrophs, parasite protein peripherally associated with the parasitophorous vacuolar membrane (e.g. P. falciparum PfCG2 [33]) may be involved in other processes of host cell cytoplasm uptake into the intracellular parasite. Better understanding these various uptake pathways and their roles in expression of DNA from plasmid-loaded RBCs may lead to improved methods for genetic transformation and provide new insights into parasite transport biology.

Supplementary Material

supplement

Table S1. Parasitemias of pHDEF1i-luc transformants collected for luciferase assay.

Table S2. Luciferase signals from cultures of P. knowlesi 48 h after electroporation of schizont infected RBCs.

Table S3. Luciferase signals from P. knowlesi transformants after 72 h of culture in electroporated rhesus RBCs.

Table S4. Luciferase signals from parasites transformed by electroporation at the developing, nearly mature, and mature-schizont stage.

Table S5. Estimated parasitemias (% of RBCs) from pD-pfCam-Luc transformants.

Table S6. Luciferase signals (LUs) from pD-pfCam-Luc transformants.

Highlights.

  • P. knowlesi parasites transform themselves by DNA uptake from host red blood cells

  • Transformation by DNA uptake is less laborious than by direct electroporation

  • Efficiency of transformation by direct electroporation varies with age of schizonts

  • DNA uptake mechanism studies may give insights into apicomplexan transport pathways

Acknowledgments

We thank Lynn Lambert, Sachy Orr-Gonzales, and Theresa Engels for providing rhesus blood and technical support. This research was supported by the Intramural Research Program of the National Institute of Allergy and Infectious Disease, National Institutes of Health.

Abbreviations

RBC

red blood cell

pRBC

parasitized red blood cell

hct

haematocrit

dhfr

dihydrofolate reductase gene

hdhfr

human dihydrofolate reductase gene

Footnotes

Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

Competing Interests

The authors of this manuscript declare no competing interests.

Authors’ Contributions

RMB, TJG and TEW designed studies and wrote the manuscript. RMB, TJG, WAK, and JMS performed experiments and collected data. All authors contributed revisions and approved the manuscript.

References

  • 1.Singh B, Daneshvar C. Human infections and detection of Plasmodium knowlesi. Clin Microbiol Rev. 2013;26(2):165–84. doi: 10.1128/CMR.00079-12. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Singh B, Kim Sung L, Matusop A, Radhakrishnan A, Shamsul SS, Cox-Singh J, Thomas A, Conway DJ. A large focus of naturally acquired Plasmodium knowlesi infections in human beings. Lancet. 2004;363(9414):1017–24. doi: 10.1016/S0140-6736(04)15836-4. [DOI] [PubMed] [Google Scholar]
  • 3.Daneshvar C, Davis TM, Cox-Singh J, Rafa’ee MZ, Zakaria SK, Divis PC, Singh B. Clinical and laboratory features of human Plasmodium knowlesi infection. Clin Infect Dis. 2009;49(6):852–60. doi: 10.1086/605439. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.William T, Rahman HA, Jelip J, Ibrahim MY, Menon J, Grigg MJ, Yeo TW, Anstey NM, Barber BE. Increasing incidence of Plasmodium knowlesi malaria following control of P. falciparum and P. vivax Malaria in Sabah, Malaysia. PLoS Negl Trop Dis. 2013;7(1):e2026. doi: 10.1371/journal.pntd.0002026. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Cox-Singh J, Culleton R. Plasmodium knowlesi: from severe zoonosis to animal model. Trends Parasitol. 2015;31(6):232–8. doi: 10.1016/j.pt.2015.03.003. [DOI] [PubMed] [Google Scholar]
  • 6.Murphy JR, Weiss WR, Fryauff D, Dowler M, Savransky T, Stoyanov C, Muratova O, Lambert L, Orr-Gonzalez S, Zeleski KL, Hinderer J, Fay MP, Joshi G, Gwadz RW, Richie TL, Villasante EF, Richardson JH, Duffy PE, Chen J. Using infective mosquitoes to challenge monkeys with Plasmodium knowlesi in malaria vaccine studies. Malar J. 2014;13:215. doi: 10.1186/1475-2875-13-215. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Blanquart S, Gascuel O. Mitochondrial genes support a common origin of rodent malaria parasites and Plasmodium falciparum’s relatives infecting great apes. BMC Evol Biol. 2011;11:70. doi: 10.1186/1471-2148-11-70. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Hall N. Genomic insights into the other malaria. Nat Genet. 2012;44(9):962–3. doi: 10.1038/ng.2392. [DOI] [PubMed] [Google Scholar]
  • 9.Moon RW, Hall J, Rangkuti F, Ho YS, Almond N, Mitchell GH, Pain A, Holder AA, Blackman MJ. Adaptation of the genetically tractable malaria pathogen Plasmodium knowlesi to continuous culture in human erythrocytes. Proc Natl Acad Sci U S A. 2013;110(2):531–6. doi: 10.1073/pnas.1216457110. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Kocken CH, Ozwara H, van der Wel A, Beetsma AL, Mwenda JM, Thomas AW. Plasmodium knowlesi provides a rapid in vitro and in vivo transfection system that enables double-crossover gene knockout studies. Infect Immun. 2002;70(2):655–60. doi: 10.1128/IAI.70.2.655-660.2002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Gruring C, Moon RW, Lim C, Holder AA, Blackman MJ, Duraisingh MT. Human red blood cell-adapted Plasmodium knowlesi parasites: a new model system for malaria research. Cell Microbiol. 2014;16(5):612–20. doi: 10.1111/cmi.12275. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.van der Wel AM, Tomas AM, Kocken CH, Malhotra P, Janse CJ, Waters AP, Thomas AW. Transfection of the primate malaria parasite Plasmodium knowlesi using entirely heterologous constructs. J Exp Med. 1997;185(8):1499–503. doi: 10.1084/jem.185.8.1499. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Ozwara H, van der Wel A, Kocken CH, Thomas AW. Heterologous promoter activity in stable and transient Plasmodium knowlesi transgenes. Mol Biochem Parasitol. 2003;130(1):61–4. doi: 10.1016/s0166-6851(03)00141-5. [DOI] [PubMed] [Google Scholar]
  • 14.Pasini EM, Zeeman AM, Voorberg VANDERWA, Kocken CH. Plasmodium knowlesi: a relevant, versatile experimental malaria model. Parasitology. 2016:1–15. doi: 10.1017/S0031182016002286. [DOI] [PubMed] [Google Scholar]
  • 15.Janse CJ, Ramesar J, Waters AP. High-efficiency transfection and drug selection of genetically transformed blood stages of the rodent malaria parasite Plasmodium berghei. Nat Protoc. 2006;1(1):346–56. doi: 10.1038/nprot.2006.53. [DOI] [PubMed] [Google Scholar]
  • 16.Deitsch K, Driskill C, Wellems T. Transformation of malaria parasites by the spontaneous uptake and expression of DNA from human erythrocytes. Nucleic Acids Res. 2001;29(3):850–3. doi: 10.1093/nar/29.3.850. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Hasenkamp S, Russell KT, Horrocks P. Comparison of the absolute and relative efficiencies of electroporation-based transfection protocols for Plasmodium falciparum. Malar J. 2012;11:210. doi: 10.1186/1475-2875-11-210. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Calderwood MS, Gannoun-Zaki L, Wellems TE, Deitsch KW. Plasmodium falciparum var genes are regulated by two regions with separate promoters, one upstream of the coding region and a second within the intron. J Biol Chem. 2003;278(36):34125–32. doi: 10.1074/jbc.M213065200. [DOI] [PubMed] [Google Scholar]
  • 19.Sa JM, Yamamoto MM, Fernandez-Becerra C, de Azevedo MF, Papakrivos J, Naude B, Wellems TE, Del Portillo HA. Expression and function of pvcrt-o, a Plasmodium vivax ortholog of pfcrt, in Plasmodium falciparum and Dictyostelium discoideum. Mol Biochem Parasitol. 2006;150(2):219–28. doi: 10.1016/j.molbiopara.2006.08.006. [DOI] [PubMed] [Google Scholar]
  • 20.Hayton K, Gaur D, Liu A, Takahashi J, Henschen B, Singh S, Lambert L, Furuya T, Bouttenot R, Doll M, Nawaz F, Mu J, Jiang L, Miller LH, Wellems TE. Erythrocyte binding protein PfRH5 polymorphisms determine species-specific pathways of Plasmodium falciparum invasion. Cell Host Microbe. 2008;4(1):40–51. doi: 10.1016/j.chom.2008.06.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Auliff AM, Balu B, Chen N, O’Neil MT, Cheng Q, Adams JH. Functional analysis of Plasmodium vivax dihydrofolate reductase-thymidylate synthase genes through stable transformation of Plasmodium falciparum. PLoS One. 2012;7(7):e40416. doi: 10.1371/journal.pone.0040416. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Fidock DA, Nomura T, Talley AK, Cooper RA, Dzekunov SM, Ferdig MT, Ursos LM, Sidhu AB, Naude B, Deitsch KW, Su XZ, Wootton JC, Roepe PD, Wellems TE. Mutations in the P. falciparum digestive vacuole transmembrane protein PfCRT and evidence for their role in chloroquine resistance. Mol Cell. 2000;6(4):861–71. doi: 10.1016/s1097-2765(05)00077-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Wahlgren M, Berzins K, Perlmann P, Bjorkman A. Characterization of the humoral immune response in Plasmodium falciparum malaria. I. Estimation of antibodies to P. falciparum or human erythrocytes by means of microELISA. Clin Exp Immunol. 1983;54(1):127–34. [PMC free article] [PubMed] [Google Scholar]
  • 24.Kite WA, Melendez-Muniz VA, Moraes Barros RR, Wellems TE, Sa JM. Alternative methods for the Plasmodium falciparum artemisinin ring-stage survival assay with increased simplicity and parasite stage-specificity. Malar J. 2016;15:94. doi: 10.1186/s12936-016-1148-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.van den Hoff MJ, Moorman AF, Lamers WH. Electroporation in ‘intracellular’ buffer increases cell survival. Nucleic Acids Res. 1992;20(11):2902. doi: 10.1093/nar/20.11.2902. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Coatney GR. The primate malarias. U.S. National Institute of Allergy and Infectious Diseases; Bethesda, Md: 1971. [Google Scholar]
  • 27.Hasenkamp S, Merrick CJ, Horrocks P. A quantitative analysis of Plasmodium falciparum transfection using DNA-loaded erythrocytes. Mol Biochem Parasitol. 2013;187(2):117–20. doi: 10.1016/j.molbiopara.2013.01.001. [DOI] [PubMed] [Google Scholar]
  • 28.Epp C, Raskolnikov D, Deitsch KW. A regulatable transgene expression system for cultured Plasmodium falciparum parasites. Malar J. 2008;7:86. doi: 10.1186/1475-2875-7-86. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Spadafora C, Gerena L, Kopydlowski KM. Comparison of the in vitro invasive capabilities of Plasmodium falciparum schizonts isolated by Percoll gradient or using magnetic based separation. Malar J. 2011;10:96. doi: 10.1186/1475-2875-10-96. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Rosazza C, Buntz A, Riess T, Woll D, Zumbusch A, Rols MP. Intracellular tracking of single-plasmid DNA particles after delivery by electroporation. Mol Ther. 2013;21(12):2217–26. doi: 10.1038/mt.2013.182. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Elliott DA, McIntosh MT, Hosgood HD, 3rd, Chen S, Zhang G, Baevova P, Joiner KA. Four distinct pathways of hemoglobin uptake in the malaria parasite Plasmodium falciparum. Proc Natl Acad Sci U S A. 2008;105(7):2463–8. doi: 10.1073/pnas.0711067105. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Milani KJ, Schneider TG, Taraschi TF. Defining the morphology and mechanism of the hemoglobin transport pathway in Plasmodium falciparum-infected erythrocytes. Eukaryot Cell. 2015;14(4):415–26. doi: 10.1128/EC.00267-14. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Cooper RA, Papakrivos J, Lane KD, Fujioka H, Lingelbach K, Wellems TE. PfCG2, a Plasmodium falciparum protein peripherally associated with the parasitophorous vacuolar membrane, is expressed in the period of maximum hemoglobin uptake and digestion by trophozoites. Mol Biochem Parasitol. 2005;144(2):167–76. doi: 10.1016/j.molbiopara.2005.07.009. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

supplement

Table S1. Parasitemias of pHDEF1i-luc transformants collected for luciferase assay.

Table S2. Luciferase signals from cultures of P. knowlesi 48 h after electroporation of schizont infected RBCs.

Table S3. Luciferase signals from P. knowlesi transformants after 72 h of culture in electroporated rhesus RBCs.

Table S4. Luciferase signals from parasites transformed by electroporation at the developing, nearly mature, and mature-schizont stage.

Table S5. Estimated parasitemias (% of RBCs) from pD-pfCam-Luc transformants.

Table S6. Luciferase signals (LUs) from pD-pfCam-Luc transformants.

RESOURCES